Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives

SIMPLE SUMMARY: Altered regulation of the cell cycle is a hallmark of cancer. The recent clinical success of the inhibitors of CDK4 and CDK6 has convincingly demonstrated that targeting cell cycle components may represent an effective anti-cancer strategy, at least in some cancer types. However, pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall’Acqua, Alessandra, Bartoletti, Michele, Masoudi-Khoram, Nastaran, Sorio, Roberto, Puglisi, Fabio, Belletti, Barbara, Baldassarre, Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235237/
https://www.ncbi.nlm.nih.gov/pubmed/34204543
http://dx.doi.org/10.3390/cancers13123035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235237/
https://www.ncbi.nlm.nih.gov/pubmed/34204543
http://dx.doi.org/10.3390/cancers13123035

Ejemplares similares